Our perspectives
in one place
Topic
Selected filters
Clear
News
See all78th WHO Regional Committee for the Americas: Briefing session – reforming the global health architecture
On 2 October 2026 in Washington, D.C., IFPMA delivered a statement on reforming the global health architecture as a special briefing session following the 78th Regional Committee for the Americas. IFPMA welcomes this discussion on global health architecture reform and emphasizes the need for an architecture that fosters innovation, strengthens health systems, and forges partnerships...
Read more78th WHO Regional Committee for the Americas: Policy on the application of data science in public health using artificial intelligence and other emerging technologies
On 1 October 2026 in Washington, D.C., IFPMA delivered a statement on the policy on the application of data science in public health using artificial intelligence and other emerging technologies at the 63rd Directing Council of the Pan American Health Organization and ahead of the 78th WHO Regional Committee for the Americas. We commend PAHO...
Read more78th WHO Regional Committee for the Americas: Plan of action for cervical cancer prevention and control 2018-2030
On 1 October 2026 in Washington, D.C., IFPMA delivered a statement on the plan of action for cervical cancer prevention and control 2018-2030 at the 63rd Directing Council of the Pan American Health Organization and ahead of the 78th WHO Regional Committee for the Americas. We welcome the progress achieved by PAHO and countries across...
Read more78th WHO Regional Committee for the Americas: Strategy for strengthening health emergency and risk management for health security 2026-2031
On 29 September 2026 in Washington, D.C., IFPMA delivered a statement on the strategy for strengthening health emergency and risk management for health security 2026-2031 at the 63rd Directing Council of the Pan American Health Organization and ahead of the 78th WHO Regional Committee for the Americas. IFPMA welcomes the Strategy for Health Emergency Risk...
Read moreConsideration of the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR)
On 25 September 2026, at the conclusion of the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response, IFPMA issued a statement, urging governments to accelerate practical commitments that strengthen preparedness for future health crises.
Read more
UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response: Panel 2
Read morePublications
See allHealthy planet, healthy people: The innovative pharmaceutical industry’s contribution to the Kunming-Montreal Global Biodiversity Framework
Through company-level initiatives and decades of pre-competitive collaboration, IFPMA member companies are working to reduce environmental impact and contribute positively to a healthy and biodiverse planet.
Read more
International data flows: Enabling data-driven, patient-centric innovative pharmaceutical research and development (R&D)
To fulfill the potential of data and new technologies in supporting the shared objective of improving patient lives and population health, it is vital that well-designed systems are put in place.
Read more
Enabling innovation: The R&D ecosystem for medicines and vaccines
Decisive policy action is critical to sustain innovation that improves people’s lives. This position paper illustrates the R&D ecosystem in action, and underscores the importance of continued commitment by governments and across stakeholders to ensure the conditions that enable the development and delivery of transformative medicines and vaccines.
Read more
Expert insights
See all
From pilots to pipelines: What WIPO’s Global Innovation Index highlights about innovation ecosystems
Read more
Longer healthier lives, stronger economies: The potential for Europe’s preventive care agenda to set a global example
Read more
Japan can lead the world in making preventive health pay
Read moreResources
See allAdult immunization for healthy workforces and healthy economies in an aging world
IFPMA and the Global Coalition on Ageing (GCOA) outline why vaccination is essential to building healthier workforces and stronger economies in an aging world.
Read more
Streamlining samples management to strengthen health outcomes in Africa
Ensuring the quality, safety, and efficacy of pharmaceutical products is a cornerstone of public health. To meet these high standards, innovative multinational pharmaceutical companies perform rigorous batch release testing for every product, following internationally recognized protocols and approved specifications. However, countries may require additional in-country testing by their National Regulatory Authorities (NRAs) or National Control...
Read more
Our Ethos in Action – Decision-Making Framework Toolkit
IFPMA has developed a Five-Phase Decision-Making Framework, grounded in the IFPMA Ethos or value system, to help companies make decisions that balance business objectives and ethical considerations to meet patient needs and the expectations of the medical community, regulators, and society.
Read more